Search
for
Sort by
Research 31–60 of 1000+
- Bad Hair Day: Testosterone and Wnts
- Hair aging and anti-aging
- Canonical prolactin signaling and global mRNA expression in the skin of Holstein heifers carrying the SLICK1 allele of the prolactin receptor gene
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Beyond acne: Current aspects of sebaceous gland biology and function
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Androgen receptors and their biology
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Epidermal expression of receptor for advanced glycation end products (RAGE) is related to inflammation and apoptosis in human skin
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Recent positive selection of a human androgen receptor/ectodysplasin A2 receptor haplotype and its relationship to male pattern baldness
- Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Glucocorticoid Receptor Mutants Demonstrate Increased Motility Inside the Nucleus of Living Cells: Time of Fluorescence Recovery After Photobleaching (FRAP) Is an Integrated Measure of Receptor Function
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Anatomical and Dermatologic Manifestations of Estrogen Deficiency in Postmenopausal Women: A Systematic Review
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Restricted effects of androgens on glucocorticoid signaling in the mouse prefrontal cortex and midbrain
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A Systematic Review of the Potential Role of Cinnamomum spp. in Modulating Insulin Sensitivity and Hyperandrogenism in Polycystic Ovary Syndrome (PCOS)
- Melatonin promotes Cashmere goat (<i>Capra hircus</i>) secondary hair follicle growth: a view from integrated analysis of long non-coding and coding RNAs